Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction
Mahmoud Abdellatif, Francisco Vasques‐Nóvoa, Viktoria Trummer-Herbst, Sylvère Durand, Franziska Koser, Moydul Islam, Jihoon Nah, Eun‐Ah Sung, Ruli Feng, Fanny Aprahamian, Andreas Prokesch, Andreas Prokesch, Junichi Sadoshima, Abhinav Diwan, Wolfgang A. Linke, João Pedro Ferreira, Guido Guido Kroemer, Simon Sedej (2025). Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction. , DOI: https://doi.org/10.1093/eurheartj/ehaf062.
Article287 days agoNicotinamide for the treatment of heart failure with preserved ejection fraction
Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser, Sylvère Durand, Rui Adão, Francisco Vasques‐Nóvoa, Johanna K. Freundt, Julia Voglhuber, María Rosaria Pricolo, Michael Kasa, Clara Türk, Fanny Aprahamian, Elías Herrero‐Galán, Sebastian J. Hofer, Tobias Pendl, Lavinia Rech, Julia Kargl, Nathaly Anto-Michel, Senka Ljubojević-Holzer, Julia Schipke, Christina Brandenberger, Martina Auer, Renate Schreiber, Chintan N. Koyani, Ákos Heinemann, Andreas Zirlik, Albrecht Schmidt, Dirk von Lewinski, Douglas S. Scherr, Peter P. Rainer, Julia von Maltzahn, Christian Mühlfeld, Marcus Krüger, Saša Frank, Frank Madeo, Tobias Eisenberg, Andreas Prokesch, Adelino Leite‐Moreira, André P. Lourenço, Jorge Alegre‐Cebollada, Stefan Kiechl, Wolfgang A. Linke, Guido Guido Kroemer, Simon Sedej (2021). Nicotinamide for the treatment of heart failure with preserved ejection fraction. , 13(580), DOI: https://doi.org/10.1126/scitranslmed.abd7064.
Article287 days agoNicotinamide for the treatment of heart failure with preserved ejection fraction
Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser, Sylvère Durand, Rui Adão, Francisco Vasques‐Nóvoa, Johanna K. Freundt, Julia Voglhuber, María Rosaria Pricolo, Michael Kasa, Clara Türk, Fanny Aprahamian, Elías Herrero‐Galán, Sebastian J. Hofer, Tobias Pendl, Lavinia Rech, Julia Kargl, Nathaly Anto-Michel, Senka Ljubojević-Holzer, Julia Schipke, Christina Brandenberger, Martina Auer, Renate Schreiber, Chintan N. Koyani, Ákos Heinemann, Andreas Zirlik, Albrecht Schmidt, Dirk von Lewinski, Douglas S. Scherr, Peter P. Rainer, Julia von Maltzahn, Christian Mühlfeld, Marcus Krüger, Saša Frank, Frank Madeo, Tobias Eisenberg, Andreas Prokesch, Adelino Leite‐Moreira, André P. Lourenço, Jorge Alegre‐Cebollada, Stefan Kiechl, Wolfgang A. Linke, Guido Guido Kroemer, Simon Sedej (2021). Nicotinamide for the treatment of heart failure with preserved ejection fraction. , 13(580), DOI: https://doi.org/10.1126/scitranslmed.abd7064.
Article287 days agoMyocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Bruno Garcia, Fuhong Su, Laurence Dewachter, Raphaël Favory, Amina Khaldi, Alexander Moiroux-Sahraoui, Filippo Annoni, Francisco Vasques‐Nóvoa, Estela Rocha-Oliveira, Roberto Roncon‐Albuquerque, Géraldine Hubesch, Hassane Njimi, Jean Louis Vincent, Fabio Silvio Taccone, Jacques Créteur, Antoine Herpain (2022). Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. , 26(1), DOI: https://doi.org/10.1186/s13054-022-04161-3.
Article43 days agoInhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
Bruno Garcia, Benoit Ter Schiphorst, Karine Santos, Fuhong Su, Laurence Dewachter, Francisco Vasques‐Nóvoa, Estela Rocha-Oliveira, Roberto Roncon‐Albuquerque, Theo Uba, Oliver Hartmann, Adrien Picod, Fériel Azibani, Jacques Callebert, Serge Goldman, Filippo Annoni, Raphaël Favory, Jean Louis Vincent, Jacques Créteur, Fabio Silvio Taccone, Alexandre Mebazaa, Antoine Herpain (2024). Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. , 12(1), DOI: https://doi.org/10.1186/s40635-024-00638-3.
Article43 days ago